Patents by Inventor Michael Dyson
Michael Dyson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240132615Abstract: The present invention relates to novel trispecific heterodimeric immunoglobulins. More specifically the present invention relates to trispecific heterodimeric immunoglobulins that target human CD3 antigen, human BCMA and human CD38 antigen. The present invention also relates to this novel class of trispecific heterodimeric immunoglobulins for use in the treatment of proliferative diseases and in particular cancers such as hematological cancer. The present invention relates to novel trispecific antibody for use in treating multiple myeloma.Type: ApplicationFiled: May 3, 2023Publication date: April 25, 2024Inventors: Maria PIHLGREN BOSCH, Mario PERRO, Olivia HALL, Laura CARRETERO IGLESIA, Adam DRAKE, Daniela PAIS, Rebecca CROASDALE-WOOD, Jérémy LOYAU, Carole ESTOPPEY, Ankita SRIVASTAVA, Michael DYSON, Julie MACOIN, Myriam CHIMEN, Thierry MONNEY, Cyrille DREYFUS
-
Patent number: 11956292Abstract: Systems and methods for streaming data in a legacy mainframe environment. In some embodiments, the method includes receiving, at a KAFKA streaming platform abstraction layer interface, production data from a first publisher application; selecting a producer instance to receive the production data; and configuring the selected producer instance with a first set of configuration parameters from at least one producer library. The method may further include communicating the first publication data to the selected producer instance; and forwarding the first publication data to a KAFKA streaming platform cluster in operable communication with a consumer instance.Type: GrantFiled: April 21, 2023Date of Patent: April 9, 2024Assignee: Rocket Software, Inc.Inventors: Michael E. Arnold, Rodney Dyson, Senthil Balasundaram, Parveen Mehta
-
Patent number: 11926818Abstract: The invention relates to methods of producing eukaryotic cell libraries encoding a repertoire of binding molecules (“binders”), wherein the methods use a site-specific nuclease for targeted cleavage of cellular DNA to enhance site-specific integration of binder genes through endogenous cellular repair mechanisms. Populations of eukaryotic cells are produced in which a repertoire of genes encoding binders are integrated into a desired locus in cellular DNA (e.g., a genomic locus) allowing expression of the encoded binding molecule, thereby creating a population of cells expressing different binders.Type: GrantFiled: February 11, 2020Date of Patent: March 12, 2024Assignee: Iontas LimitedInventors: John McCafferty, Michael Dyson, Kothai Parthiban
-
Patent number: 11912984Abstract: The invention relates to methods of producing eukaryotic cell libraries encoding a repertoire of binding molecules (“binders”), wherein the methods use a site-specific nuclease for targeted cleavage of cellular DNA to enhance site-specific integration of binder genes through endogenous cellular repair mechanisms. Populations of eukaryotic cells are produced in which a repertoire of genes encoding binders are integrated into a desired locus in cellular DNA (e.g., a genomic locus) allowing expression of the encoded binding molecule, thereby creating a population of cells expressing different binders.Type: GrantFiled: February 11, 2020Date of Patent: February 27, 2024Assignee: Iontas LimitedInventors: John McCafferty, Michael Dyson, Kothai Parthiban
-
Publication number: 20230212288Abstract: The invention relates to the field of immunology and biotechnology, and also to the creation of novel effective high-molecular compounds having therapeutic properties. Variants of amino acid sequences of complementarity-determining regions (CDR) of antigen-binding fragments of a protein molecule specific to human cell CD3 receptors are proposed. The proposed CDR can be used for engineering various antigen-binding molecules, one of the essential function of which is a specific interaction with CD3-bearing cells. Bispecific molecules that specifically bind to human cell CD3 and CD19 receptors were engineered by means of the inclusion of said CDR in the composition of an antibody-like molecule intrinsically binding to the CD19 receptor.Type: ApplicationFiled: August 20, 2020Publication date: July 6, 2023Inventors: Aleksandr Aleksandrovich PISKUNOV, Svetlana Georgievna ABBASOVA, Anton Nikolaevich MOROZOV, Aleksandr Mikhailovich SHUSTER, Peter SLAVNY, Daniel GRIFFITHS, Izabela KACZYNSKA, John MCCAFFERTY, Michael DYSON
-
Patent number: 11286477Abstract: The invention relates to methods of producing eukaryotic cell libraries encoding a repertoire of binding molecules (“binders”), wherein the methods use a site-specific nuclease for targeted cleavage of cellular DNA to enhance site-specific integration of binder genes through endogenous cellular repair mechanisms. Populations of eukaryotic cells are produced in which a repertoire of genes encoding binders are integrated into a desired locus in cellular DNA (e.g., a genomic locus) allowing expression of the encoded binding molecule, thereby creating a population of cells expressing different binders.Type: GrantFiled: May 1, 2015Date of Patent: March 29, 2022Assignee: Iontas LimitedInventors: John McCafferty, Michael Dyson, Kothai Parthiban
-
Publication number: 20210301022Abstract: An antibody molecule, or antigen-binding fragment thereof capable of binding specifically to PD-L1.Type: ApplicationFiled: July 12, 2019Publication date: September 30, 2021Applicant: F-Star Beta LimitedInventors: Francisca Wollerton, Matthew Lakins, Mateusz Wydro, Sachin Surade, Michael Dyson
-
Publication number: 20200165596Abstract: The invention relates to methods of producing eukaryotic cell libraries encoding a repertoire of binding molecules (“binders”), wherein the methods use a site-specific nuclease for targeted cleavage of cellular DNA to enhance site-specific integration of binder genes through endogenous cellular repair mechanisms. Populations of eukaryotic cells are produced in which a repertoire of genes encoding binders are integrated into a desired locus in cellular DNA (e.g., a genomic locus) allowing expression of the encoded binding molecule, thereby creating a population of cells expressing different binders.Type: ApplicationFiled: February 11, 2020Publication date: May 28, 2020Applicant: IONTAS LIMITEDInventors: John McCafferty, Michael Dyson, Kothai Parthiban
-
Publication number: 20200165595Abstract: The invention relates to methods of producing eukaryotic cell libraries encoding a repertoire of binding molecules (“binders”), wherein the methods use a site-specific nuclease for targeted cleavage of cellular DNA to enhance site-specific integration of binder genes through endogenous cellular repair mechanisms. Populations of eukaryotic cells are produced in which a repertoire of genes encoding binders are integrated into a desired locus in cellular DNA (e.g., a genomic locus) allowing expression of the encoded binding molecule, thereby creating a population of cells expressing different binders.Type: ApplicationFiled: February 11, 2020Publication date: May 28, 2020Applicant: IONTAS LIMITEDInventors: John McCafferty, Michael Dyson, Kothai Parthiban
-
Publication number: 20200165597Abstract: The invention relates to methods of producing eukaryotic cell libraries encoding a repertoire of binding molecules (“binders”), wherein the methods use a site-specific nuclease for targeted cleavage of cellular DNA to enhance site-specific integration of binder genes through endogenous cellular repair mechanisms. Populations of eukaryotic cells are produced in which a repertoire of genes encoding binders are integrated into a desired locus in cellular DNA (e.g., a genomic locus) allowing expression of the encoded binding molecule, thereby creating a population of cells expressing different binders.Type: ApplicationFiled: February 11, 2020Publication date: May 28, 2020Applicant: IONTAS LIMITEDInventors: John McCafferty, Michael Dyson, Kothai Parthiban
-
Publication number: 20190256840Abstract: This invention relates to libraries of binding members that each comprise a fusion protein which contains a donor diversity scaffold domain, such as a cysteine rich protein, inserted within a recipient diversity scaffold domain, such as an antibody constant or variable domain. Libraries and methods of generating libraries are provided, along with screening methods, binding members and methods of using the binding members.Type: ApplicationFiled: January 9, 2017Publication date: August 22, 2019Applicant: IONTAS LTDInventors: Aneesh Karatt Vellatt, John McCafferty, Sachin Surade, Tim Luetkens, Edward Masters, Michael Dyson
-
Patent number: 10336356Abstract: A wheeled shipping/transport cart includes a cart frame that supports a plurality of wheels. The cart frame supports a plurality of stackable trays. The trays include a tray frame with opposed end members, a plurality of longitudinal support members disposed between the opposed end members, and a plurality of upright members nesting with upright members of an adjacent tray. A support structure is disposed between the opposed end members to form an arc corresponding to a curved surface of an article to be supported by the support structure. A pin is received through each of the upright members of the plurality of stackable trays to retain the stackable trays in a stacked configuration.Type: GrantFiled: June 21, 2017Date of Patent: July 2, 2019Assignee: Globe Composite Solutions, Ltd.Inventor: Michael Dyson
-
Publication number: 20170369087Abstract: A wheeled shipping/transport cart includes a cart frame that supports a plurality of wheels. The cart frame supports a plurality of stackable trays. The trays include a tray frame with opposed end members, a plurality of longitudinal support members disposed between the opposed end members, and a plurality of upright members nesting with upright members of an adjacent tray. A support structure is disposed between the opposed end members to form an arc corresponding to a curved surface of an article to be supported by the support structure. A pin is received through each of the upright members of the plurality of stackable trays to retain the stackable trays in a stacked configuration.Type: ApplicationFiled: June 21, 2017Publication date: December 28, 2017Applicant: Globe Composite Solutions, Ltd.Inventor: Michael Dyson
-
Publication number: 20170073664Abstract: The invention relates to methods of producing eukaryotic cell libraries encoding a repertoire of binding molecules (“binders”), wherein the methods use a site-specific nuclease for targeted cleavage of cellular DNA to enhance site-specific integration of binder genes through endogenous cellular repair mechanisms. Populations of eukaryotic cells are produced in which a repertoire of genes encoding binders are integrated into a desired locus in cellular DNA (e.g., a genomic locus) allowing expression of the encoded binding molecule, thereby creating a population of cells expressing different binders.Type: ApplicationFiled: May 1, 2015Publication date: March 16, 2017Applicant: IONTAS LIMITEDInventors: John McCafferty, Michael Dyson, Kothai Parthiban
-
Publication number: 20090239761Abstract: The inventors herein describe methods for the production of a functional human, animal, plant or microbe protein arrays and methods to assay for interactions between the proteins on the array with molecules of interest, for example, using such arrays to determine the in vitro metabolite profile of any drug. Such protein arrays can be used, for example, to assay, in a parallel fashion, the protein products of DNA sequences encoding drug metabolizing enzymes (DMES) to obtain a toxicology profile. Also described herein is a novel DME expression and purification strategy using detergents and not requiring an ultra-centrifugation step.Type: ApplicationFiled: November 10, 2008Publication date: September 24, 2009Inventors: Jonathan Michael Blackburn, Benjamin Leslie James Godber, Darren James Hart, Nicholas A. Bockett, Roland Kozlowski, Michael Dyson
-
Publication number: 20060199220Abstract: The Inventors herein describe methods for the production of a functional human, animal, plant or microbe protein arrays and methods to assay for interactions between the proteins on the array with molecules of interest, for example, using such arrays to determine the in vitro metabolite profile of any drug. Such protein arrays can be used, for example, to assay, in a parallel fashion, the protein products of DNA sequences encoding drug metabolising enzymes (DMEs) to obtain a toxicology profile. Also described herein is a novel DME expression and purification strategy using detergents and not requiring an ultra-centrifugation step.Type: ApplicationFiled: September 16, 2003Publication date: September 7, 2006Inventors: Jonathan Blackburn, Benjamin Godber, Darren Hart, Nicholas Bockett, Roland Kozlowski, Michael Dyson
-
Publication number: 20050221308Abstract: The use of a tag moiety comprising a biotinylation domain, such as biotin carboxyl carrier protein (BCCP), as a protein folding marker and protein solubility enhancer in the orientated surface capture of products of heterologously expressed genes is described. Methods for increasing the solubility of proteins and determining the folded state of a protein are also disclosed. The uses and methods of the invention can be carried out in a multiplexed manner on more than one protein in the formation of libraries. In addition the nucleic acid molecule encoding the biotinylation domain of the tag moiety can be used to increase the proportion of clones in a library that express the protein of interest.Type: ApplicationFiled: January 29, 2003Publication date: October 6, 2005Inventors: Mitali Samaddar, Jonathan Blackburn, Darren Hart, Michael Dyson
-
Publication number: 20050214285Abstract: The present invention relates to the provision of novel medicaments for the treatment, prevention or amelioration of allergic disease. In particular, the novel medicaments are isolated peptides incorporating epitopes or mimotopes of surface exposed regions of the C?2 domain of IgE. The inventors have found that these novel regions may be the target for both passive and active immunoprophylaxis or immunotherapy. The invention further relates to methods for production of the medicaments, pharmaceutical compositions containing them and their use in medicine. Also forming an aspect of the present invention are ligands, especially monoclonal antibodies, which are capable of binding the surface exposed IgE regions of the present invention, and their use in medicine as passive immunotherapy or in immunoprophylaxis.Type: ApplicationFiled: December 7, 2004Publication date: September 29, 2005Inventors: Michael Dyson, Martin Friede, Judith Greenwood, Ellen Hewitt, Alan Lamont, Sean Mason, Roger Randall, William Turnell, Marcelle Van Mechelen, Carlotta y de Bassols
-
Publication number: 20050013704Abstract: A portable air compressor unit (10) having a housing (22) with a rear end (30) and front end (26). The housing (22) includes a rear louver (66) near the rear end (30), an exhaust outlet (74) near the front end (26) and a mid louver (70) between the rear and front end. A rear cooler set (82) and rear fan (106) are disposed within the housing between the rear louver and mid louver. The fan (106) draws cooling air into the housing through rear louver (66) and through the rear cooler set (82). A front fan (122) and front cooler set (130) are disposed within the housing (22) between the mid louver (70) and exhaust outlet (74).Type: ApplicationFiled: December 28, 2001Publication date: January 20, 2005Inventors: Michael Dyson, Marion Hancock, Dean Hendrix, David Stahlman, Donald Wood